Radiation resistance of cancer stem cells as an obstacle in cancer therapy

S. Chumsri, P. Shah
{"title":"Radiation resistance of cancer stem cells as an obstacle in cancer therapy","authors":"S. Chumsri, P. Shah","doi":"10.4255/MCPHARMACOL.13.06","DOIUrl":null,"url":null,"abstract":"Sh Faisal 14.00 Radiation represents an important therapeutic intervention in many tumor types. Nevertheless, tumor recurrence continues to post major limitation to this type of therapy. Wealth of data suggests that there is a distinct population of cancer cells with exclusive ability to self-renew, termed cancer stem cells (CSCs). This subset of cancer cells has been shown to be resistant to conventional therapy, including chemotherapy and radiation. Failure to eradicate CSCs may result in tumor recurrence. This review article summarized the characteristic and identification of CSCs along with mechanisms of resistance in these cells including increased DNA repair. Understanding the mechanisms underlying radioresistance of CSCs will lead to better combination therapies to overcome resistance of these cells which will ultimately improve outcome for radiation treatment. Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ \n table.MsoNormalTable \n {mso-style-name:\"Table Normal\"; \n mso-tstyle-rowband-size:0; \n mso-tstyle-colband-size:0; \n mso-style-noshow:yes; \n mso-style-priority:99; \n mso-style-parent:\"\"; \n mso-padding-alt:0in 5.4pt 0in 5.4pt; \n mso-para-margin:0in; \n mso-para-margin-bottom:.0001pt; \n mso-pagination:widow-orphan; \n font-size:12.0pt; \n font-family:\"Calibri\",\"sans-serif\"; \n mso-ascii-font-family:Calibri; \n mso-ascii-theme-font:minor-latin; \n mso-hansi-font-family:Calibri; \n mso-hansi-theme-font:minor-latin;}","PeriodicalId":18748,"journal":{"name":"Molecular and cellular pharmacology","volume":"1 1","pages":"39-49"},"PeriodicalIF":0.0000,"publicationDate":"2013-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"16","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular and cellular pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4255/MCPHARMACOL.13.06","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 16

Abstract

Sh Faisal 14.00 Radiation represents an important therapeutic intervention in many tumor types. Nevertheless, tumor recurrence continues to post major limitation to this type of therapy. Wealth of data suggests that there is a distinct population of cancer cells with exclusive ability to self-renew, termed cancer stem cells (CSCs). This subset of cancer cells has been shown to be resistant to conventional therapy, including chemotherapy and radiation. Failure to eradicate CSCs may result in tumor recurrence. This review article summarized the characteristic and identification of CSCs along with mechanisms of resistance in these cells including increased DNA repair. Understanding the mechanisms underlying radioresistance of CSCs will lead to better combination therapies to overcome resistance of these cells which will ultimately improve outcome for radiation treatment. Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin;}
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肿瘤干细胞的耐辐射性是肿瘤治疗中的一个障碍
放射是许多肿瘤类型的重要治疗干预手段。然而,肿瘤复发仍然是这种治疗的主要限制。大量数据表明,存在一种独特的具有自我更新能力的癌细胞群,称为癌症干细胞(CSCs)。这部分癌细胞已被证明对包括化疗和放疗在内的常规治疗具有耐药性。不能根除csc可能导致肿瘤复发。本文综述了CSCs的特点和鉴定,以及这些细胞的耐药机制,包括DNA修复的增加。了解CSCs放射耐药的机制将导致更好的联合治疗来克服这些细胞的耐药,最终改善放射治疗的结果。正常0 false false false EN-US X-NONE X-NONE /*样式定义*/表。mso-style-name:"Table Normal";mso-tstyle-rowband-size: 0;mso-tstyle-colband-size: 0;mso-style-noshow:是的;mso-style-priority: 99;mso-style-parent:“”;mso- font - family:宋体;mso-para-margin: 0;mso-para-margin-bottom: .0001pt;mso-pagination: widow-orphan;字体大小:12.0分;字体类型:“Calibri”、“无衬线”;mso-ascii-font-family: Calibri;mso-ascii-theme-font: minor-latin;mso-hansi-font-family: Calibri;mso-hansi-theme-font: minor-latin;}
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.00
自引率
0.00%
发文量
0
期刊最新文献
Sacituzumab govitecan for hormone receptor-positive and triple-negative breast cancers. Protein Kinase D: A Potential Therapeutic Target in Prostate Cancer. RNA-binding Protein, GADD45-alpha, p27Kip1, p53 and Genotoxic Stress Response in Relation to Chemoresistance in Cancer. mTOR Inhibitors at a Glance. Curcumin-encapsulating Nanogels as an Effective Anticancer Formulation for Intracellular Uptake.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1